BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 37760437)

  • 1. MicroRNAs Can Influence Ovarian Cancer Progression by Dysregulating Integrin Activity.
    Fasoulakis Z; Psarommati MZ; Papapanagiotou A; Pergialiotis V; Koutras A; Douligeris A; Mortaki A; Mihail A; Theodora M; Stavros S; Karakalpakis D; Papamihail M; Kontomanolis EN; Daskalakis G; Antsaklis P
    Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment.
    Ahmed N; Riley C; Rice G; Quinn M
    Clin Exp Metastasis; 2005; 22(5):391-402. PubMed ID: 16283482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and cellular mechanisms controlling integrin-mediated cell adhesion and tumor progression in ovarian cancer metastasis: a review.
    Dhaliwal D; Shepherd TG
    Clin Exp Metastasis; 2022 Apr; 39(2):291-301. PubMed ID: 34822024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrins in cell adhesion and signaling.
    Akiyama SK
    Hum Cell; 1996 Sep; 9(3):181-6. PubMed ID: 9183647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of Integrins in Gastrointestinal Cancer Metastasis.
    Hou S; Wang J; Li W; Hao X; Hang Q
    Front Mol Biosci; 2021; 8():708779. PubMed ID: 34869579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond adhesion: emerging roles for integrins in control of the tumor microenvironment.
    Longmate W; DiPersio CM
    F1000Res; 2017; 6():1612. PubMed ID: 29026524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrins regulate stemness in solid tumor: an emerging therapeutic target.
    Xiong J; Yan L; Zou C; Wang K; Chen M; Xu B; Zhou Z; Zhang D
    J Hematol Oncol; 2021 Oct; 14(1):177. PubMed ID: 34715893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STROBE-compliant integrin through focal adhesion involve in cancer stem cell and multidrug resistance of ovarian cancer.
    Wei L; Yin F; Zhang W; Li L
    Medicine (Baltimore); 2017 Mar; 96(12):e6345. PubMed ID: 28328815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-31 is a broad regulator of β1-integrin expression and function in cancer cells.
    Augoff K; Das M; Bialkowska K; McCue B; Plow EF; Sossey-Alaoui K
    Mol Cancer Res; 2011 Nov; 9(11):1500-8. PubMed ID: 21875932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Every step of the way: integrins in cancer progression and metastasis.
    Hamidi H; Ivaska J
    Nat Rev Cancer; 2018 Sep; 18(9):533-548. PubMed ID: 30002479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrins Within the Tumor Microenvironment: Biological Functions, Importance for Molecular Targeting, and Cancer Therapeutics Innovation.
    Dzobo K
    OMICS; 2021 Jul; 25(7):417-430. PubMed ID: 34191612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor suppressor KAI1 affects integrin alphavbeta3-mediated ovarian cancer cell adhesion, motility, and proliferation.
    Ruseva Z; Geiger PX; Hutzler P; Kotzsch M; Luber B; Schmitt M; Gross E; Reuning U
    Exp Cell Res; 2009 Jun; 315(10):1759-71. PubMed ID: 19371633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and function of beta 1 and alpha v beta 3 integrins in ovarian cancer.
    Cannistra SA; Ottensmeier C; Niloff J; Orta B; DiCarlo J
    Gynecol Oncol; 1995 Aug; 58(2):216-25. PubMed ID: 7542622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrins and haptoglobin: Molecules overexpressed in ovarian cancer.
    Villegas-Pineda JC; Garibay-Cerdenares OL; Hernández-Ramírez VI; Gallardo-Rincón D; Cantú de León D; Pérez-Montiel-Gómez MD; Talamás-Rohana P
    Pathol Res Pract; 2015 Dec; 211(12):973-81. PubMed ID: 26549463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adhesion molecules.
    Skubitz AP
    Cancer Treat Res; 2002; 107():305-29. PubMed ID: 11775459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs and Long Noncoding RNAs as Novel Therapeutic Targets in Estrogen Receptor-Positive Breast and Ovarian Cancers.
    Barwal TS; Sharma U; Bazala S; Singh I; Jain M; Prakash H; Shekhar S; Sandberg EN; Bishayee A; Jain A
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting ILK and β4 integrin abrogates the invasive potential of ovarian cancer.
    Choi YP; Kim BG; Gao MQ; Kang S; Cho NH
    Biochem Biophys Res Commun; 2012 Oct; 427(3):642-8. PubMed ID: 23026047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidance of Signaling Activations by Cadherins and Integrins in Epithelial Ovarian Cancer Cells.
    Roggiani F; Mezzanzanica D; Rea K; Tomassetti A
    Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27563880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs as Biomarkers for Early Diagnosis, Prognosis, and Therapeutic Targeting of Ovarian Cancer.
    Mirahmadi Y; Nabavi R; Taheri F; Samadian MM; Ghale-Noie ZN; Farjami M; Samadi-Khouzani A; Yousefi M; Azhdari S; Salmaninejad A; Sahebkar A
    J Oncol; 2021; 2021():3408937. PubMed ID: 34721577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orphan nuclear receptor TR3/Nur77 differentially regulates the expression of integrins in angiogenesis.
    Ye T; Peng J; Liu X; Hou S; Niu G; Li Y; Zeng H; Zhao D
    Microvasc Res; 2019 Mar; 122():22-33. PubMed ID: 30391133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.